SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001821825-22-000006
Filing Date
2022-05-06
Accepted
2022-05-05 21:16:53
Documents
85
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ogn-20220331.htm   iXBRL 10-Q 1456880
2 EX-31.1 ogn3312022ex311.htm EX-31.1 7683
3 EX-31.2 ogn3312022ex312.htm EX-31.2 7804
4 EX-32.1 ogn3312022ex321.htm EX-32.1 3769
5 EX-32.2 ogn3312022ex322.htm EX-32.2 3477
  Complete submission text file 0001821825-22-000006.txt   8002830

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ogn-20220331.xsd EX-101.SCH 60764
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ogn-20220331_cal.xml EX-101.CAL 75234
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ogn-20220331_def.xml EX-101.DEF 285858
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ogn-20220331_lab.xml EX-101.LAB 678340
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ogn-20220331_pre.xml EX-101.PRE 460641
79 EXTRACTED XBRL INSTANCE DOCUMENT ogn-20220331_htm.xml XML 1489209
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

IRS No.: 464838035 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40235 | Film No.: 22898581
SIC: 2834 Pharmaceutical Preparations